广济药业：第十一届董事会第十次会议决议公告

Group 1 - The company Guangji Pharmaceutical announced the approval of multiple proposals during the 10th meeting of its 11th Board of Directors, including the convening of the third temporary shareholders' meeting in 2025 [2]